|
|
|
|
|
|
|
MediciNova- Inc. (MNOV)
|
|
8.61 0.05 (0.58%)
|
06-22 16:00
|
|
Open:
|
8.61
|
Pre. Close:
|
8.56
|
|
High:
|
8.98
|
Low:
|
8.4
|
|
Volume:
|
437,970
|
Market Cap:
|
354M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
8.963 - 9
|
9 - 9.037
|
|
Low:
|
8.315 - 8.351
|
8.351 - 8.388
|
|
Close:
|
8.55 - 8.614
|
8.614 - 8.679
|
|
|
|
Technical analysis (as of: 2018-06-22 4:32:47 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.
|
|
Target:
|
Six months: 11.06 One year: 12.00
|
|
Support:
|
Support1: 8.18 Support2: 6.81
|
|
Resistance:
|
Resistance1:
9.47 Resistance2: 10.27
|
|
Pivot:
|
8.86
|
|
Moving Averages:
|
MA(5): 8.49  MA(20): 8.99
MA(100): 10.79 MA(250): 8.01
|
|
MACD:
|
MACD(12,26):
-0.47 Signal(12,26,9): -0.49
|
|
%K %D:
|
%K(14,3): 26.78 %D(3): 21.26
|
|
RSI:
|
RSI(14): 32.43
|
|
52-Week:
|
High: 14.5
Low: 4.4 Change(%): 57.7
|
|
Average Vol(K):
|
3-Month: 18600
10-Days 10171
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.MNOV has closed above bottom band by 32.7%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to MNOV's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-05-02T10:47:42-04:00
Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH
2018-04-23T13:40:29-04:00
Biotech Forum: The Week Ahead
2018-04-19T12:04:52-04:00
Q2 2018 Biotech Catalyst Watchlist: Phase 2 Clinical Trials
2018-04-17T08:00:00-04:00
3 Things In Biotech, April 16: Liver, Liver, And More Liver
2018-04-16T08:00:00-04:00
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data
2018-04-13T09:56:25-04:00
Key events next week - healthcare
2018-04-13T07:03:34-04:00
MediciNova's tipelukast shows treatment effect in mid-stage NASH/NAFLD study; shares up 8% premarket
2018-04-05T08:16:00-04:00
3 Things In Biotech, April 4: Olaparib To Europe Again
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
